

Armadin tablets are indicated for the treatment of:
Active ingredient: Armadin (2-ethyl-6-methyl-3-hydroxypyridine succinate);
1 tablet contains Armadine (2-ethyl-6-methyl-3-hydroxypyridine succinate) - 125 mg;
Excipients: lactose monohydrate, potato starch; povidone, crospovidone; silicon dioxide colloidal magnesium stearate succinic acid; hydroxypropyl cellulose; talcum titanium dioxide (E 171) hydroxypropylmethyl cellulose.
Acute liver or kidney failure, hypersensitivity to the drug.
ARMADIN® is prescribed orally. The therapeutic dose and duration of treatment is determined by the doctor depending on the sensitivity of patients to the drug.
For the relief of alcohol withdrawal symptoms, the drug should be used within 5-7 days.
The duration of the course of therapy in patients with coronary heart disease is at least 1.5-2 months. Two 2-month courses of therapy are recommended during the year, in the spring-autumn period.
Terminate the course of therapy with the drug ARMADIN® gradually, reducing the dose for 2-3 days.
Not assigned.
Not assigned.
During the treatment period, care must be taken when driving or working with mechanisms, given the likelihood of side effects that can affect the speed of the reaction and the ability to concentrate.
With an overdose, drowsiness is possible. Treatment is detoxification therapy.
ARMADIN® enhances the action of benzodiazepine anxiolytics, antiparkinsonian drugs and carbamazepine. Reduces the toxic effects of ethyl alcohol.
Store at a temperature not exceeding 30 ° C in the original packaging.
Keep out of the reach of children.
Shelf life is 3 years.